These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1162 related items for PubMed ID: 22435854
1. Prospective evaluation of anticoagulation and transjugular intrahepatic portosystemic shunt for the management of portal vein thrombosis in cirrhosis. Senzolo M, M Sartori T, Rossetto V, Burra P, Cillo U, Boccagni P, Gasparini D, Miotto D, Simioni P, Tsochatzis E, A Burroughs K. Liver Int; 2012 Jul; 32(6):919-27. PubMed ID: 22435854 [Abstract] [Full Text] [Related]
3. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosis. Han G, Qi X, He C, Yin Z, Wang J, Xia J, Yang Z, Bai M, Meng X, Niu J, Wu K, Fan D. J Hepatol; 2011 Jan; 54(1):78-88. PubMed ID: 20932597 [Abstract] [Full Text] [Related]
4. Transjugular intrahepatic portosystemic shunt creation for cirrhotic portal hypertension is well tolerated among patients with portal vein thrombosis. Merola J, Fortune BE, Deng Y, Ciarleglio M, Amirbekian S, Chaudhary N, Shanbhogue A, Ayyagari R, Rodriguez-Davalos MI, Teperman L, Charles HW, Sigal SH. Eur J Gastroenterol Hepatol; 2018 Jun; 30(6):668-675. PubMed ID: 29462027 [Abstract] [Full Text] [Related]
7. Safety and efficacy of anticoagulation therapy with low molecular weight heparin for portal vein thrombosis in patients with liver cirrhosis. Amitrano L, Guardascione MA, Menchise A, Martino R, Scaglione M, Giovine S, Romano L, Balzano A. J Clin Gastroenterol; 2010 Jul; 44(6):448-51. PubMed ID: 19730112 [Abstract] [Full Text] [Related]
8. Safety and Efficacy of Transjugular Intrahepatic Portosystemic Shunt for Non-tumoral Cirrhotic Portal Vein Thrombosis Not Responding to Anticoagulation Therapy. Mukund A, Marri UK, Jindal A, Choudhury A, Patidar Y, Sarin SK. Dig Dis Sci; 2023 Jul; 68(7):3174-3184. PubMed ID: 37169934 [Abstract] [Full Text] [Related]
9. Transjugular local thrombolysis with/without TIPS in patients with acute non-cirrhotic, non-malignant portal vein thrombosis. Klinger C, Riecken B, Schmidt A, De Gottardi A, Meier B, Bosch J, Caca K. Dig Liver Dis; 2017 Dec; 49(12):1345-1352. PubMed ID: 28733177 [Abstract] [Full Text] [Related]
11. Clinical outcomes of transcatheter selective superior mesenteric artery urokinase infusion therapy vs transjugular intrahepatic portosystemic shunt in patients with cirrhosis and acute portal vein thrombosis. Jiang TT, Luo XP, Sun JM, Gao J. World J Gastroenterol; 2017 Nov 07; 23(41):7470-7477. PubMed ID: 29151701 [Abstract] [Full Text] [Related]
18. Portal vein thrombosis in cirrhotic patients - it is always the small pieces that make the big picture. Gîrleanu I, Trifan A, Stanciu C, Sfarti C. World J Gastroenterol; 2018 Oct 21; 24(39):4419-4427. PubMed ID: 30356984 [Abstract] [Full Text] [Related]
19. Comparison of transjugular intrahepatic portosystemic with endoscopic treatment plus anticoagulation for esophageal variceal bleeding and portal vein thrombosis in liver cirrhosis. Wu W, Zhang H, Zeng Z, Wang X, Kong D. Scand J Gastroenterol; 2022 Dec 21; 57(12):1494-1502. PubMed ID: 35802771 [Abstract] [Full Text] [Related]
20. Short- and long-term effects of the transjugular intrahepatic portosystemic shunt on portal vein thrombosis in patients with cirrhosis. Luca A, Miraglia R, Caruso S, Milazzo M, Sapere C, Maruzzelli L, Vizzini G, Tuzzolino F, Gridelli B, Bosch J. Gut; 2011 Jun 21; 60(6):846-52. PubMed ID: 21357252 [Abstract] [Full Text] [Related] Page: [Next] [New Search]